Glucagon-like peptide (GLP)-2 reduces chemotherapy-associated mortality and enhances cell survival in cells expressing a transfected GLP-2 receptor.
about
Combination treatment of db/db mice with exendin-4 and gastrin preserves β-cell mass by stimulating β-cell growth and differentiation.Gut hormones, and short bowel syndrome: the enigmatic role of glucagon-like peptide-2 in the regulation of intestinal adaptation.Stem cells as potential therapeutic targets for inflammatory bowel disease.Gut adaptation and the glucagon-like peptidesThe effects of fluorouracil, epirubicin, and cyclophosphamide (FEC60) on the intestinal barrier function and gut peptides in breast cancer patients: an observational study.The role of gut hormones in glucose homeostasisGlucagon-like peptide 2 (GLP-2) accelerates the growth of colonic neoplasms in mice.Glucagon-like peptide-2-stimulated protein synthesis through the PI 3-kinase-dependent Akt-mTOR signaling pathway.Intestinotrophic glucagon-like peptide-2 (GLP-2) activates intestinal gene expression and growth factor-dependent pathways independent of the vasoactive intestinal peptide gene in miceDisruption of the murine Glp2r impairs Paneth cell function and increases susceptibility to small bowel enteritisPreclinical efficacy of a carboxylesterase 2-activated prodrug of doxazolidine.Gastro-intestinal toxicity of chemotherapeutics in colorectal cancer: the role of inflammation.Discovery, characterization, and clinical development of the glucagon-like peptides.
P2860
Q33609727-5D52FCE2-79EC-4B43-BD83-B210EC1BB19AQ33865971-0D43364A-3BD3-437C-BAB5-5599E964B944Q33975300-605D0948-354B-47D8-92A6-6DB51172FD37Q34526042-32BB2134-2079-471E-970E-98CFBF18156FQ34573812-3F1EADC9-8F28-4221-B0BF-53E08B7A8F49Q35251016-5FBA7DAA-8CF4-4BD1-8B1B-DBAF3865F4E1Q35596753-0A626159-26BE-4C36-83A6-55FB32C87BB9Q35756432-C83A9DEB-CC9C-452D-9EDB-4ECD26641A81Q35986076-1A348F70-08DD-4D20-B8BE-07BED140CE19Q36710034-95CE3F8E-1F5F-4F16-A774-9AEFF83BDBBEQ37459147-3E4FD12F-A88F-4002-8BD8-458E21836ED5Q37697523-8A406EAB-1342-4E77-8C9C-7FFDB3ABB444Q47333882-787A6AD9-51FE-426B-B9D9-E801E5E5DA7A
P2860
Glucagon-like peptide (GLP)-2 reduces chemotherapy-associated mortality and enhances cell survival in cells expressing a transfected GLP-2 receptor.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Glucagon-like peptide (GLP)-2 ...... a transfected GLP-2 receptor.
@ast
Glucagon-like peptide (GLP)-2 ...... a transfected GLP-2 receptor.
@en
type
label
Glucagon-like peptide (GLP)-2 ...... a transfected GLP-2 receptor.
@ast
Glucagon-like peptide (GLP)-2 ...... a transfected GLP-2 receptor.
@en
prefLabel
Glucagon-like peptide (GLP)-2 ...... a transfected GLP-2 receptor.
@ast
Glucagon-like peptide (GLP)-2 ...... a transfected GLP-2 receptor.
@en
P2093
P1433
P1476
Glucagon-like peptide (GLP)-2 ...... g a transfected GLP-2 receptor
@en
P2093
P304
P407
P577
2001-01-01T00:00:00Z